Recent US Food and Drug Administration warnings to foreign and domestic OTC drug firms about failing to test ingredients for diethylene glycol and ethylene glycol substitution are the latest indications that, as an agency official says, ‘“sadly, FDA has a long history with DEG/EG poisonings.”
In a presentation prepared for a recent pharmaceutical manufacturing regulatory conference, Francis Godwin, manufacturing quality director in the FDA Center...